← Leaderboards
Toshihiko Ezashi
University Of Missouri-Columbia
$1,558,888
Attributed
$4,136,806
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $639.7K · FY2013–22$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,136,806 · 3
By mechanism
R01$3,710,556 · 2
R21$426,250 · 1
Top collaborators
- Danny J Schust13 shared
- Robert Michael Roberts5 shared
- Laura Clamon Schulz5 shared
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Danny J Schust$11,685,332
Others in their field
Top investigators on “Syncytiotrophoblast”
- Mana M Parast · University Of California, San Diego$15,724,140
- Susan J. Fisher · University Of California San Francisco$9,260,937
- Eugene D Albrecht · University Of Maryland Baltimore$7,970,235
- Carole R. Mendelson · University Of Texas Sw Med Ctr/Dallas$5,306,390
- Liping Feng · Duke University$4,639,707
- Lenore Palma Pereira · University Of California San Francisco$4,552,436
Research focus
SyncytiotrophoblastHuman Embryonic Stem CellPre-EclampsiaStem CellsTissuesBmp4PlacentaIn VitroPremature BirthInvadedPlacentationCellsTrophoblastMothersInduced Pluripotent Stem CellFetal Growth RetardationCytotrophoblastEventFirst Pregnancy TrimesterPregnancyPerfusionOxygenPlacenta DiseasesConceptus
Grant awards (13)
Modeling normal and abnormal trophoblasts$358,551
R01 · FY2022 · HD
Modeling normal and abnormal trophoblasts$358,551
R01 · FY2021 · HD
VTCN1 regulation of MHC in early human placental development$193,750
R21 · FY2021 · AI
Modeling normal and abnormal trophoblasts$407,227
R01 · FY2020 · HD
VTCN1 regulation of MHC in early human placental development$232,500
R21 · FY2020 · AI
Modeling normal and abnormal trophoblasts$450,099
R01 · FY2019 · HD
Modeling normal and abnormal trophoblasts$463,632
R01 · FY2018 · HD
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$318,513
R01 · FY2017 · HD · contact PI
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$315,327
R01 · FY2016 · HD · contact PI
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$100,000
R01 · FY2016 · HD · contact PI
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$310,549
R01 · FY2015 · HD · contact PI
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$309,594
R01 · FY2014 · HD · contact PI
Pluripotent Stem Cells: Modeling syncytiotrophoblast development and pathogenesis$318,513
R01 · FY2013 · HD · contact PI